Allergy Therapeutics (AGY), the specialist pharmaceutical company focused on allergy vaccination, announced that the European Patent office has granted a broad technology patent relating to the company's family of MPL-based sublingual allergy vaccines.
the details can be read here.
No comments:
Post a Comment